Cargando…

Health-Related and Economic Burden Among Family Caregivers of Patients with Acute Myeloid Leukemia or Hematological Malignancies

INTRODUCTION: Acute myeloid leukemia (AML) is associated with lower survival and greater unmet need compared with some other hematologic malignancies (HMs). Despite differences in acuteness between AML and other HMs, the burden of family caregivers (FCs) of patients with these malignancies offer sim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yucel, Emre, Zhang, Shiyu, Panjabi, Sumeet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478752/ https://www.ncbi.nlm.nih.gov/pubmed/34499319 http://dx.doi.org/10.1007/s12325-021-01872-x

Ejemplares similares

Economic burden of disease progression among multiple myeloma patients who have received transplant and at least one line of therapy in the US
por: Fonseca, Rafael, et al.
Publicado: (2021)

The Economic Burden of Acute Myeloid Leukemia in Iran
por: Alipour, Vahid, et al.
Publicado: (2022)

Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia – a single center analysis
por: Sandner, Anne-Sophie, et al.
Publicado: (2019)

Family Aggregation of Hematological Malignancies Discovered from an Acute Myeloid Leukemia Patient with STK11 and THBD Gene Mutation
por: Zhang, Nan, et al.
Publicado: (2023)

Spontaneous hematological remission of acute myeloid leukemia
por: Kaźmierczak, Maciej, et al.
Publicado: (2014)

Economic burden of acute myeloid leukemia on patients in a resource-limited tertiary hospital in the Philippines
por: Catapia, Jean Rachel M., et al.
Publicado: (2023)

Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome
por: Guijarro, Francesca, et al.
Publicado: (2023)

The social and economic burden on family caregivers for older adults in the Czech Republic
por: Maresova, Petra, et al.
Publicado: (2020)

Homoharringtonine and omacetaxine for myeloid hematological malignancies
por: Lü, Shuqing, et al.
Publicado: (2014)

MicroRNAs in Myeloid Hematological Malignancies
por: Ciccone, Maria, et al.
Publicado: (2015)

The mortality burden of hematological malignancies in Ecuador
por: Garrido, David, et al.
Publicado: (2021)

Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies
por: Bertoli, Sarah, et al.
Publicado: (2016)

The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia
por: Muñoz, Miguel, et al.
Publicado: (2020)

Nucleophosmin1 (NPM1) abnormality in hematologic malignancies, and therapeutic targeting of mutant NPM1 in acute myeloid leukemia
por: Chen, Yingyu, et al.
Publicado: (2020)

Burden of caregiving and its impact in the patients of acute lymphoblastic leukemia
por: Kumari, Rina, et al.
Publicado: (2018)

Burden, satisfaction caregiving, and family relations in informal caregivers of older adults
por: Marinho, Jéssica da Silva, et al.
Publicado: (2022)

Economic burden of illness among patients with pulmonary arterial hypertension (PAH) associated with connective tissue disorders (CTD)
por: Tsang, Yuen, et al.
Publicado: (2023)

Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01
por: Miyamoto, Kenichi, et al.
Publicado: (2019)

Burden Experience of Caregivers of Acute Lymphoblastic Leukemia: Impact of Coping and Spirituality
por: Chivukula, Usha, et al.
Publicado: (2018)

Clinical insights into hematologic malignancies and comparative analysis of molecular signatures of acute myeloid leukemia in different ethnicities using an artificial intelligence offering
por: Snowdon, Jane L., et al.
Publicado: (2021)

TP53-mutant myelodysplastic syndrome and acute myeloid leukemia: the black hole of hematology
por: Patel, Shyam A., et al.
Publicado: (2022)

PB1843: ACUTE MYELOID LEUKEMIA WITH PHILADELPHIA CHROMOSOME: EXPERIENCE OF SFAX HEMATOLOGY DEPARTMENT
por: Siala, N., et al.
Publicado: (2022)

Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies
por: Palumbo, Giuseppe Alberto, et al.
Publicado: (2019)

Burden and Anxiety in Family Caregivers in the Hospital That Debut in Caregiving
por: Pérez-Cruz, Margarita, et al.
Publicado: (2019)

Family impact and economic burden among caregivers of children with chronic kidney disease in Assiut, Egypt
por: Darwish, Manal M, et al.
Publicado: (2020)

The Role of the HOXA Gene Family in Acute Myeloid Leukemia
por: Chen, Si-Liang, et al.
Publicado: (2019)

Germline CEBPA mutation in familial acute myeloid leukemia
por: Boada, Matilde, et al.
Publicado: (2021)

Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
por: Yuan, Ji, et al.
Publicado: (2023)

Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels
por: Guillaumet-Adkins, Amy, et al.
Publicado: (2014)

Social and economic incentives for family Caregivers
por: Horowitz, Amy, et al.
Publicado: (1983)

P1723: A FEASIBILITY STUDY OF PEER SUPPORT IN FAMILY CAREGIVERS OF PATIENTS NEWLY DIAGNOSED WITH HEMATOLOGIC MALIGNANCY
por: Nielsen, I. H., et al.
Publicado: (2022)

Identifying childhood leukemia with an excess of hematological malignancies in first-degree relatives in Brazil
por: Mendes-de-Almeida, Daniela P., et al.
Publicado: (2023)

Predictors of caregiver burden in Iranian family caregivers of cancer patients
por: Mirsoleymani, Seyed Reza, et al.
Publicado: (2017)

Caregiver Burden and Sleep Quality in Dependent People’s Family Caregivers
por: Simón, Miguel A., et al.
Publicado: (2019)

Caregiver burden and the associated factors in the family caregivers of patients with schizophrenia
por: Rahmani, Farnaz, et al.
Publicado: (2022)

Estimation of minimally important differences and responder definitions for EORTC QLQ‐MY20 scores in multiple myeloma patients
por: Sully, Kate, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies
por: De Veirman, Kim, et al.
Publicado: (2014)

Myeloid-derived suppressor cells in hematological malignancies: friends or foes
por: Lv, Meng, et al.
Publicado: (2019)

Incidence and Bayesian Mapping of Myeloid Hematologic Malignancies in Sardinia, Italy
por: Broccia, Giorgio, et al.
Publicado: (2023)

What Does the Economic Burden of Acute Myeloid Leukemia Treatment Look Like for the Next Decade? An Analysis of Key Findings, Challenges and Recommendations
por: Forsythe, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a7tsk3103i332i85cfl4ua8k6s